Aurora

Researchers are conducting a non-interventional, open-label, observational study across multiple sites to collect real-world data on the use of an autologous hair follicle derived secretome topical cosmetic product. This product is studied as an addition to various medical aesthetic procedures, focusing on its application for conditions such as post-procedural erythema. The study includes adults aged 18 to 60 of any skin type who are planning to undergo these aesthetic treatments. Participants will use the Acorn Autologous Hair Follicle Secretome cosmetic product following their medical aesthetic procedures. The procedures involved include laser resurfacing of the face (ablative or non-ablative), Tixel treatment of the face, and treatments for acne and surgery scars combined with ablative or non-ablative laser or microneedling. Some hair-related treatments and procedures are closed to enrollment. The study observes real-world usage without intervening in treatment decisions. During the study, participants will be monitored for symptoms and downtime related to their procedures over a period of 1 to 7 days. Researchers will collect data on post-procedure symptoms and downtime using questionnaires to understand the product's impact as an adjunct to aesthetic procedures. The study ensures safety by excluding participants with conditions that may interfere with participation and by tracking any relevant health status changes throughout the observation period.